Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects - PubMed (original) (raw)
Review
Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects
Peter Thomas et al. Steroids. 2013 Jun.
Abstract
The protective functions of progesterone in the cardiovascular system have received little attention even though evidence has accumulated that progesterone lowers blood pressure, inhibits coronary hyperactivity and has powerful vasodilatory and natriuretic effects. One possible reason why potential beneficial actions of progesterone on cardiovascular functions have not been extensively studied is that divergent effects to those of progesterone have been observed in many clinical trials with synthetic progestins such as medroxyprogesterone acetate which are associated with increased risk of coronary disease. Evidence that progesterone exerts protective effects on cardiovascular functions is briefly reviewed. The finding that progesterone administration decreases blood vessel vasoconstriction in several animal models within a few minutes suggests that rapid, nongenomic progesterone mechanisms are of physiological importance in regulating vascular tone. Rapid activation of second messenger pathways by progesterone has been observed in vascular endothelial and smooth muscle cells, resulting in alterations in endothelial nitric oxide synthase (eNOS) activity and calcium influx, respectively. Both nuclear progesterone receptors (PRs) and novel membrane progesterone receptors (mPRs) are candidates for the intermediaries in these rapid, cell-surface initiated progesterone actions in endothelial and smooth muscle vascular cells. PRs have been detected in both cell types. New data are presented showing mPRα, mPRβ and mPRγ are also present in human endothelial and smooth muscle vascular cells. Preliminary evidence suggests mPRs mediate rapid progestin signaling in these endothelial cells, resulting in down-regulation of cAMP production and increased nitric oxide synthesis. The role of mPRs in progesterone regulation of cardiovascular functions warrants further investigation.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Progesterone increases nitric oxide synthesis in human vascular endothelial cells through activation of membrane progesterone receptor-α.
Pang Y, Dong J, Thomas P. Pang Y, et al. Am J Physiol Endocrinol Metab. 2015 May 15;308(10):E899-911. doi: 10.1152/ajpendo.00527.2014. Epub 2015 Mar 24. Am J Physiol Endocrinol Metab. 2015. PMID: 25805192 - Human homologs of the putative G protein-coupled membrane progestin receptors (mPRalpha, beta, and gamma) localize to the endoplasmic reticulum and are not activated by progesterone.
Krietsch T, Fernandes MS, Kero J, Lösel R, Heyens M, Lam EW, Huhtaniemi I, Brosens JJ, Gellersen B. Krietsch T, et al. Mol Endocrinol. 2006 Dec;20(12):3146-64. doi: 10.1210/me.2006-0129. Epub 2006 Sep 7. Mol Endocrinol. 2006. PMID: 16959873 - Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions.
Thomas P. Thomas P. Front Neuroendocrinol. 2008 May;29(2):292-312. doi: 10.1016/j.yfrne.2008.01.001. Epub 2008 Feb 1. Front Neuroendocrinol. 2008. PMID: 18343488 Free PMC article. Review. - Role of mPRα (PAQR7) in progesterone-induced Ca2+ decrease in human vascular smooth muscle cells.
Pang Y, Thomas P. Pang Y, et al. J Mol Endocrinol. 2019 Oct;63(3):199-213. doi: 10.1530/JME-19-0019. J Mol Endocrinol. 2019. PMID: 31416049 - Candidates for membrane progestin receptors--past approaches and future challenges.
Zhu Y, Hanna RN, Schaaf MJ, Spaink HP, Thomas P. Zhu Y, et al. Comp Biochem Physiol C Toxicol Pharmacol. 2008 Nov;148(4):381-9. doi: 10.1016/j.cbpc.2008.05.019. Epub 2008 Jun 15. Comp Biochem Physiol C Toxicol Pharmacol. 2008. PMID: 18602498 Review.
Cited by
- Reply to Wang et al.: Body size and composition are the primary contributors to human thermoregulatory variation by sex.
Brychta RJ, LaMunion SR, Courville AB, Reitman ML, Cypess AM, Chen KY. Brychta RJ, et al. Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2414221121. doi: 10.1073/pnas.2414221121. Epub 2024 Sep 23. Proc Natl Acad Sci U S A. 2024. PMID: 39312664 Free PMC article. No abstract available. - Beyond reproduction: unraveling the impact of sex hormones on cardiometabolic health.
Xega V, Liu JL. Xega V, et al. Med Rev (2021). 2024 May 23;4(4):284-300. doi: 10.1515/mr-2024-0012. eCollection 2024 Aug. Med Rev (2021). 2024. PMID: 39135604 Free PMC article. Review. - Beyond Menstrual Dysfunction: Does Altered Endocrine Function Caused by Problematic Low Energy Availability Impair Health and Sports Performance in Female Athletes?
Ihalainen JK, Mikkonen RS, Ackerman KE, Heikura IA, Mjøsund K, Valtonen M, Hackney AC. Ihalainen JK, et al. Sports Med. 2024 Sep;54(9):2267-2289. doi: 10.1007/s40279-024-02065-6. Epub 2024 Jul 12. Sports Med. 2024. PMID: 38995599 Free PMC article. Review. - Cardiac Autonomic Balance Is Altered during the Acute Stress Response in Adolescent Major Depression-Effect of Sex.
Tonhajzerova I, Ferencova N, Ondrejka I, Hrtanek I, Farsky I, Kukucka T, Visnovcova Z. Tonhajzerova I, et al. Life (Basel). 2023 Nov 20;13(11):2230. doi: 10.3390/life13112230. Life (Basel). 2023. PMID: 38004370 Free PMC article. - Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction: A comprehensive literature review.
Abubakar M, Saleem A, Hajjaj M, Faiz H, Pragya A, Jamil R, Salim SS, Lateef IK, Singla D, Ramar R, Damara I, Shahid L. Abubakar M, et al. Heart Fail Rev. 2024 Jan;29(1):235-256. doi: 10.1007/s10741-023-10369-4. Epub 2023 Nov 24. Heart Fail Rev. 2024. PMID: 37996694 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources